Home / PBIGF : OTC

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does PBIGF make money? Does PBIGF have pricing power? What's the Earnings Whisper? Will PBIGF profit more as the business scales? What is PBIGF's management track record? Is PBIGF's current price justified?

Paradigm Biopharmaceuticals Limited

$0.01 -$0.22 (-94.89%)

OTC · 30 Oct 2026 20:00 UTC

Previous Close

$0.01

Day Range

$0.00$0.01

Year Range

$0.00$0.30

Market Cap

7.45M

AVG Volume

37.35K

Trailing/Forward PE

-1.61/-

PEG ratio

0.17

Dividend Yield

Next Earnings Date

2027-02-24

Primary Exchange

Other OTC

Revenue (AUD) · Q

PBIGF Revenue (AUD) by quarter
Period	Revenue (AUD)
26 Q4	54.92K
26 Q2	25.14K
25 Q4	35.42K
25 Q2	16.7K
24 Q4	65.8K
24 Q2	0
23 Q4	42.05K
23 Q2	4.71K
22 Q4	34.02K
22 Q2	45.2K

Net Income (AUD) · Q

PBIGF Net Income (AUD) by quarter
Period	Net Income (AUD)
26 Q4	-33.04M
26 Q2	-23.24M
25 Q4	-12.85M
25 Q2	-5.92M
24 Q4	-9.7M
24 Q2	-48.96M
23 Q4	-20.04M
23 Q2	-31.87M
22 Q4	-12.27M
22 Q2	-26.98M

Operating Income (AUD) · Q

PBIGF Operating Income (AUD) by quarter
Period	Operating Income (AUD)
26 Q4	-39.23M
26 Q2	-21.82M
25 Q4	-16.8M
25 Q2	-6.35M
24 Q4	-14.97M
24 Q2	-50.15M
23 Q4	-26.92M
23 Q2	-32.76M
22 Q4	-19.75M
22 Q2	-27.26M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (AUD) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 24 Feb 2027.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Paradigm Biopharmaceuticals Limited

Earnings: PBIGF

Video analysis: PBIGF

News: PBIGF

Similar companies